Health Catalyst (HCAT) shares fell 2.5% in Friday trading after Canaccord Genuity downgraded the stock to hold from buy and cut its price target to $1.80 from $3.
Intraday volume topped 744,130 shares, compared with the daily average of 1.65 million.
Price: $1.59, Change: $-0.04, Percent Change: -2.45%
VirTra (VTSI) won a $1.5 million US Army contract to deploy its simulation-based firearms training system in Tajikistan, the company said Thursday.The company will supply its V-300 platform, including simulation software, weapon recoil kits, and associated hardware to support partner-force readiness.VirTra shares rose 2.3% in after-hours trading.
James Hardie Industries (JHX) agreed to sell its European sustainable walling and flooring solutions business, Fermacell, including the fermacell and Aestuver brands, to Holcim for 840 million euros ($981 million) in cash.James Hardie said Thursday it also plans to close its European fiber cement business, subject to customary legal, regulatory and employee consultation requirements.The company intends to use transaction proceeds to repay debt and return capital to shareholders. James Hardie's board has authorized a new $250 million share repurchase program.The transaction is expected to close in H1 2027.James Hardie shares rose 1.1% in after-hours trading.
Ross Stores (ROST) reported fiscal Q2 earnings late Thursday of $2.66 per diluted share, up from $1.56 a year earlier.Analysts polled by FactSet expected $1.95.Revenue in the three months ended Aug. 1 rose to $6.26 billion from $5.53 billion a year earlier.Analysts projected $6.16 billion.The company expects fiscal Q3 EPS of $1.75 to $1.83. Analysts project $1.75.Ross Stores expects fiscal Q4 EPS of $2.17 to $2.26. Analysts project $2.14.The company lifted full-year EPS guidance to $8.61 to $8.77 from the prior forecast of $7.50 to $7.74. Analysts project $7.89.Ross Stores shares rose 4.7% in after-hours trading.